Skip to content
healthcare.dev

imatinib mesylate

NDC 0832-0533, imatinib mesylate, tablet, from Upsher-Smith Laboratories, LLC.

Product NDC
0832-0533
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212135
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0533 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMATINIB MESYLATE400 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
0832-0533-030083205330330 TABLET in 1 BOTTLE (0832-0533-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5d07ac08-962e-41a8-8a3c-50febc8c5f34
  • NADAC price for package 00832053303

    GET /v1/drugs/nadac/00832053303

Use it

Look up 0832-0533 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0533 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0832-0533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.